retatrutide test kit Vial of unapproved peptide had double the strength indicated on label Reta (RUO) | GIP/GLP-1/GCG Agonist

this may constitute a protocol deviation requiring formal documentation and reporting Do not source retatrutide outside of an approved clinical trial it is not currently licensed for use in the UK, and obtaining it through unofficial channels carries significant safety and legal risks Consult the MHRA website (www.gov.uk/mhra) for the latest information on the regulatory status of retatrutide in the UK Once retatrutide receives regulatory approval, an official SmPC will be published, providing definitive storage guidance for both healthcare professionals and patients

See transparent pricing

Broader reviews on dietary fiber and health also support the role of fermentable fibers in metabolic outcomes here

It is up to you which one works best for you

Leone FT, Evers-Casey S